logo
  Join        Login             Stock Quote

Illumina (ILMN) Says Court Agrees To Review Patent Decision

 November 26, 2012 07:20 AM
 


(By Balachander) Illumina Inc. (NASDAQ: ILMN) said a U.S. District Court has agreed to review its earlier decision invalidating certain claims of the company's ‘597 patent.

The U.S. District Court for the Northern District of California granted Illumina's request to file a motion seeking reconsideration of the Court's October 16, 2012 ruling invalidating certain claims of U.S. Patent No. 6,306,597, which is being asserted by Illumina against Complete Genomics Inc. (NASDAQ: GNOM).

[Related -Futures Up After Apple, Inc. (AAPL) Earnings; Maidenform Brands, Inc. (MFB) Surges On Buyout News]

Under the Court's order, Illumina said it is permitted to file briefing asking the Court to reconsider its earlier ruling invalidating claims 14 and 15 of the ‘597 patent.

Illumina said it will seek a January 8, 2013 hearing date on the motion for reconsideration.

"We continue to believe that this patent covers important and novel inventions that Complete Genomics has misappropriated," commented Illumina CEO Jay Flatley. 

San Diego, California-based Illumina owns or has exclusive licenses to more than 250 patents granted in the U.S. and many additional patents granted worldwide.

Illumina provides genetic analysis services, including sequencing, genotyping, gene expression, and molecular diagnostics. The company is organized in two business segments: Life Sciences and Diagnostics.

[Related -Stocks Rally On Earnings, Housing Data; Coach (COH) Jumps]

Mountain View, California-based Complete Genomics is a developer of DNA sequencing platform. As of June 30, its backlog was around 4,600 genomes, including about 1,000 genomes booked in the second quarter, representing an aggregate revenue potential of roughly $22 million.

ILMN shares ended at $52.93 on Friday, while GNOM shares closed at $3.14.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageOld Bank's New Breakout has Big Rally Potential

One of my favorite things to see in a long candidate is a pattern of beating Wall Street's earnings read on...

article imageIs The Stock Market's 5-Year Return A Useful Proxy For Valuation?

Tobin’s Q, a market-valuation metric, is back in the news, in part thanks to a widely read Bloomberg read on...

article image4 Dogs To Sell Immediately

Despite the chorus of analysts and investors calling for the long-awaited correction, the market is showing read on...

article imageThe Fed's Magical Mystery Tour

What's going on at the Fed? Notorious dove, Charles Evans of the Chicago Fed, gave a speech in read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.